Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 1 | FDP00015 | IM / LA |
The treatment was the firs of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
None reported
HIV disease Screen for STD (sexually transmitted disease) Screening for tuberculosis Bipolar II disorder Problem related to psychosocial circumstances Abnormal second heart sound (S2) Anal fissure and fistula History of bacterial endocarditis Cervical spinal stenosis GAD (generalized anxiety disorder) PTSD (post-traumatic stress disorder) OCD (obsessive compulsive disorder) History of hepatitis C - SVR s/p DAA Tx Severe anal dysplasia, histologically confirmed History of acne Hepatitis B immune Alcohol use disorder, moderate, dependence Current every day nicotine vaping Vitamin D deficiency Research study patient History of methadone use History of COVID-19 Closed supracondylar fracture of left humerus Chronic pain syndrome Opioid use disorder, severe, in sustained remission Methamphetamine use disorder, moderate, in sustained remission Hypertriglyceridemia History of anal dysplasia STD exposure
risperiDONE (RISPERDAL) 1 mg tab risperiDONE (RISPERDAL) 0.5 mg tab darunavir-cobi-emtri-tenof ALAFENAMIDE (SYMTUZA) 800-150-200-10 mg tab folic acid (FOLVITE) 1 mg tab ibuprofen (MOTRIN) 800 mg tab tadalafil (CIALIS) 10 mg tablet
NKDA
N/A